Stay updated on Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now indicates recruitment is no longer open to participants. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment heading formatting was adjusted with the revision note updated to v3.6.0.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This signals a minor internal update to the page's revision history rather than a user-facing change.SummaryDifference0.0%

- Check41 days agoChange DetectedA new page revision entry v3.5.4 has been added to the revision history, and the previous revision v3.5.3 has been removed from the list.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page header/footer version has been updated from v3.5.2 to v3.5.3, reflecting a software/interface release rather than an update to the trial information.SummaryDifference0.0%

- Check69 days agoChange DetectedUpdated collaborator listing from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd., and updated the revision to v3.5.2 (replacing v3.5.0).SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This reflects an incremental system update and does not modify study content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in CNS and Testicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.